Annual Operating Profit
-$206.06 M
-$59.16 M-40.27%
December 31, 2023
Summary
- As of February 7, 2025, DAWN annual operating income is -$206.06 million, with the most recent change of -$59.16 million (-40.27%) on December 31, 2023.
- During the last 3 years, DAWN annual operating profit has fallen by -$192.28 million (-1395.17%).
- DAWN annual operating profit is now -1395.17% below its all-time high of -$13.78 million, reached on December 31, 2020.
Performance
DAWN Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
$29.64 M
+$144.44 M+125.81%
September 30, 2024
Summary
- As of February 7, 2025, DAWN quarterly operating income is $29.64 million, with the most recent change of +$144.44 million (+125.81%) on September 30, 2024.
- Over the past year, DAWN quarterly operating profit has increased by +$89.15 million (+149.79%).
- DAWN quarterly operating profit is now -62.40% below its all-time high of $78.81 million, reached on March 1, 2019.
Performance
DAWN Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$211.46 M
+$81.07 M+27.71%
September 30, 2024
Summary
- As of February 7, 2025, DAWN TTM operating income is -$211.46 million, with the most recent change of +$81.07 million (+27.71%) on September 30, 2024.
- Over the past year, DAWN TTM operating profit has dropped by -$5.39 million (-2.62%).
- DAWN TTM operating profit is now -229.96% below its all-time high of $162.71 million, reached on September 1, 2019.
Performance
DAWN TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
DAWN Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -40.3% | +149.8% | -2.6% |
| 3 y3 years | -1395.2% | +174.7% | -67.6% |
| 5 y5 years | -1282.5% | +174.7% | -67.6% |
DAWN Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -183.3% | at low | at high | +125.8% | -190.7% | +27.7% |
| 5 y | 5-year | -1395.2% | at low | at high | +125.8% | -234.9% | +27.7% |
| alltime | all time | -1395.2% | at low | -62.4% | +125.8% | -230.0% | +27.7% |
Day One Biopharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $29.64 M(-125.8%) | -$211.46 M(-27.7%) |
| Jun 2024 | - | -$114.81 M(+72.0%) | -$292.53 M(+28.9%) |
| Mar 2024 | - | -$66.77 M(+12.2%) | -$226.98 M(+10.1%) |
| Dec 2023 | -$206.06 M(+40.3%) | -$59.52 M(+15.7%) | -$206.06 M(+8.9%) |
| Sep 2023 | - | -$51.44 M(+4.4%) | -$189.29 M(+6.6%) |
| Jun 2023 | - | -$49.25 M(+7.4%) | -$177.55 M(+7.6%) |
| Mar 2023 | - | -$45.85 M(+7.3%) | -$165.02 M(+12.3%) |
| Dec 2022 | -$146.91 M(+102.0%) | -$42.74 M(+7.7%) | -$146.91 M(+16.5%) |
| Sep 2022 | - | -$39.70 M(+8.1%) | -$126.14 M(+19.4%) |
| Jun 2022 | - | -$36.72 M(+32.3%) | -$105.68 M(+25.2%) |
| Mar 2022 | - | -$27.75 M(+26.3%) | -$84.40 M(+16.0%) |
| Dec 2021 | -$72.74 M | -$21.98 M(+14.2%) | -$72.74 M(+27.8%) |
| Sep 2021 | - | -$19.24 M(+24.6%) | -$56.91 M(+38.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$15.44 M(-4.0%) | -$41.23 M(+46.7%) |
| Mar 2021 | - | -$16.09 M(+161.8%) | -$28.10 M(+103.9%) |
| Dec 2020 | -$13.78 M(-7.5%) | -$6.14 M(+72.5%) | -$13.78 M(-369.9%) |
| Sep 2020 | - | -$3.56 M(+54.2%) | $5.11 M(-92.6%) |
| Jun 2020 | - | -$2.31 M(+30.5%) | $68.97 M(-9.5%) |
| Mar 2020 | - | -$1.77 M(-113.9%) | $76.21 M(-51.4%) |
| Dec 2019 | -$14.90 M | - | - |
| Dec 2019 | - | $12.75 M(-78.9%) | $156.79 M(-3.6%) |
| Sep 2019 | - | $60.30 M(+1122.8%) | $162.71 M(+16.1%) |
| Jun 2019 | - | $4.93 M(-93.7%) | $140.16 M(+3.3%) |
| Mar 2019 | - | $78.81 M(+322.3%) | $135.71 M(+138.5%) |
| Dec 2018 | - | $18.66 M(-50.6%) | $56.90 M(+48.8%) |
| Sep 2018 | - | $37.75 M(+7669.7%) | $38.24 M(+7769.7%) |
| Jun 2018 | - | $485.90 K | $485.90 K |
FAQ
- What is Day One Biopharmaceuticals annual operating income?
- What is the all time high annual operating profit for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals annual operating profit year-on-year change?
- What is Day One Biopharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals quarterly operating profit year-on-year change?
- What is Day One Biopharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals TTM operating profit year-on-year change?
What is Day One Biopharmaceuticals annual operating income?
The current annual operating profit of DAWN is -$206.06 M
What is the all time high annual operating profit for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high annual operating income is -$13.78 M
What is Day One Biopharmaceuticals annual operating profit year-on-year change?
Over the past year, DAWN annual operating income has changed by -$59.16 M (-40.27%)
What is Day One Biopharmaceuticals quarterly operating income?
The current quarterly operating profit of DAWN is $29.64 M
What is the all time high quarterly operating profit for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high quarterly operating income is $78.81 M
What is Day One Biopharmaceuticals quarterly operating profit year-on-year change?
Over the past year, DAWN quarterly operating income has changed by +$89.15 M (+149.79%)
What is Day One Biopharmaceuticals TTM operating income?
The current TTM operating profit of DAWN is -$211.46 M
What is the all time high TTM operating profit for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high TTM operating income is $162.71 M
What is Day One Biopharmaceuticals TTM operating profit year-on-year change?
Over the past year, DAWN TTM operating income has changed by -$5.39 M (-2.62%)